What is the maximum number of days norethindrone acetate 5 mg three times daily can be used for menstrual suppression in a reproductive‑age woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Duration of Norethindrone 5mg TID for Menstrual Suppression

For menstrual suppression in reproductive-age women, norethindrone acetate 5mg three times daily can be continued for 6 to 9 months according to FDA labeling, though this duration is based on endometriosis treatment data rather than menstrual suppression specifically. 1

FDA-Approved Duration

  • The FDA label for norethindrone acetate specifies that for endometriosis (which requires menstrual suppression), therapy may be held at 15mg daily for 6 to 9 months or until breakthrough bleeding requires temporary termination 1
  • While the FDA label describes a dose escalation protocol starting at 5mg daily and increasing to 15mg daily over several weeks for endometriosis, the 6-9 month duration at the maintenance dose provides the clearest guidance on maximum continuous use 1

Clinical Context and Dosing Considerations

  • The 5mg TID (15mg total daily) regimen you're asking about matches the maximum maintenance dose described in the FDA label for endometriosis treatment 1
  • Research demonstrates that norethindrone acetate 5mg TID (given cyclically from day 5-26) effectively reduces menstrual blood loss by 87% over 3 cycles, though only 22% of patients wished to continue this regimen due to tolerability issues 2
  • A 2023 study found that patients with obesity or heavy menstrual bleeding are less likely to achieve menstrual suppression with lower norethindrone doses, suggesting that higher doses like 5mg TID may be necessary for certain populations 3

Important Caveats

  • Breakthrough bleeding is the primary limiting factor for continuous use and may necessitate temporary discontinuation even before reaching the 6-9 month mark 1
  • The FDA label explicitly states therapy may need temporary termination when "annoying breakthrough bleeding demands" it, meaning patient tolerance rather than an arbitrary time limit often determines actual duration 1
  • There is no high-quality evidence specifically addressing safety or efficacy of norethindrone acetate 5mg TID beyond 9 months for menstrual suppression 1

Practical Algorithm

Start with 6-9 months as your maximum planned duration, but be prepared to stop earlier if:

  • Breakthrough bleeding becomes unacceptable to the patient (most common reason) 1
  • Patient develops contraindications or intolerable side effects 1

If suppression is needed beyond 9 months, consider:

  • Switching to alternative long-acting methods (levonorgestrel IUD, etonogestrel implant) which have better long-term continuation rates and can be used for years 2, 4
  • Re-evaluating the underlying indication for continuous suppression 1

Related Questions

What is the appropriate dosing regimen of norethindrone to suppress menstruation?
Can norethisterone (a progestin) halt the growth of a uterine sarcoma?
What medication can be used to delay menstruation in a 40-year-old patient?
What is the best management approach for a 54-year-old female with recurrent abnormal uterine bleeding, who has been treated with norethisterone (progestin) and has a Jadelle (levonorgestrel) implant, considering her past medical history and the need to investigate potential organic causes?
What is the best course of treatment for a female of reproductive age with no significant medical history presenting with acute abnormal uterine bleeding (AUB)?
How should a patient presenting with syncope and a holosystolic murmur be evaluated and managed emergently?
After an anterior cervical discectomy and fusion at C5‑C6, how long can I expect to be off work?
In a 33‑week pregnant woman with extra‑hepatic portal vein obstruction who had an oesophagogastroduodenoscopy (OGD) and endoscopic variceal ligation (EVL) three years ago and is currently asymptomatic, should an OGD be performed now or after delivery?
How long should I refrain from driving after undergoing anterior cervical discectomy and fusion for cervical myelopathy at C5‑C6?
What is the likely cause of a tiny clot appearing only at the start of the urinary stream with otherwise clear urine, and what work‑up and treatment are recommended?
What are the differences between schizophrenia, schizoaffective disorder, and bipolar disorder with psychotic features?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.